Clinical Trials on Plasma Concentration in Finland
Total 83 results
-
University of Eastern FinlandDSM Nutritional Products, Inc.CompletedVitamin D Receptor Target Gene Expression | Serum 25(OH)D ConcentrationFinland
-
University of HelsinkiUniversity College Cork; Finnish Institute for Health and Welfare; Technical...CompletedSerum 25-hydroxyvitamin D Concentrations (25OHD)Finland
-
University of Eastern FinlandCompletedVitamin D Receptor Target Gene Expression | Serum 25(OH)D ConcentrationFinland
-
University of HelsinkiUniversity College Cork; Technical University of DenmarkCompletedSerum 25-hydroxyvitamin D Concentrations (25OHD)Finland
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsCompleted
-
Raija SilvennoinenBristol-Myers Squibb; Amgen; Hospital District of Helsinki and UusimaaCompletedMultiple Myeloma in RelapseFinland, Sweden
-
Henrik GregersenNordic Myeloma Study GroupUnknownMultiple MyelomaFinland, Denmark, Sweden, Norway, Lithuania
-
Kuopio University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsCompleted
-
John L. ReaganThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode IslandActive, not recruiting
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
SanofiRecruitingPlasma Cell MyelomaCzechia, Australia, Chile, France, Spain, United States, Brazil, China, Greece, Japan, Korea, Republic of, Sweden, Taiwan, Finland, Italy, Russian Federation
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
European Organisation for Research and Treatment...CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Unspecified Adult Solid Tumor, Protocol Specific | Infection | Multiple Myeloma and Plasma Cell Neoplasm | Fever, Sweats, and Hot Flashes | Bone Marrow SuppressionSwitzerland, United States, Canada, United Kingdom, Belgium, Israel, Slovakia, Finland, Germany, France, Turkey, Czech Republic, Greece
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.CompletedMultiple MyelomaNorway, Sweden, Denmark, Finland, Iceland
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Spectrum Pharmaceuticals, IncCompletedLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, B-Cell, Marginal Zone | Waldenstrom Macroglobulinemia | Lymphoma, Small-CellUnited States
-
Raija SilvennoinenTakeda; Celgene; Nordic Myeloma Study GroupActive, not recruitingMultiple MyelomaNorway, Sweden, Finland, Lithuania
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Urinary Complications | Breast Adenocarcinoma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | Metastatic Malignant Neoplasm to the Bone | Musculoskeletal ComplicationUnited States, Puerto Rico
-
PfizerBristol-Myers SquibbRecruiting
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
European Society for Blood and Marrow TransplantationCompletedMultiple MyelomaAustria, Denmark, Germany, Finland, Canada, Sweden, Norway, France, Italy, United Kingdom, Turkey
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States, Puerto Rico
-
Aronex PharmaceuticalsCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Infection | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Stichting European Myeloma NetworkPfizerRecruitingSmoldering Multiple MyelomaNetherlands, France, Italy, Finland, Greece, Norway
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)Recruiting
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Belgium, Italy, Korea, Republic of, Hong Kong, Israel, Finland, Spain, Japan, United States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
Tarix PharmaceuticalsConstant Therapeutics LLCTerminatedLymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin DiseaseUnited States
-
Janssen-Cilag International NVCompletedMultiple MyelomaFrance, Poland, Belgium, Germany, Israel, Portugal, Turkey, Finland, Sweden, Netherlands, Norway
-
PfizerAvailableMultiple MyelomaUnited States, Canada
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Denmark, Australia, Belgium, Finland, Greece, Japan, Korea, Republic of, Spain, United Kingdom
-
GlaxoSmithKlineIqvia Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Hoffmann-La RocheCompleted
-
AmgenTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaNetherlands, Spain, Belgium, Austria, Switzerland, Italy, Germany, France, Ireland, United Kingdom, Denmark, Finland, Portugal, Turkey, Poland, Estonia, Greece, Norway, Slovakia, Sweden
-
AbbVieTerminatedCancer | Multiple Myeloma (MM)United States, Australia, France, Israel, Japan, Spain, Taiwan
-
Janssen Scientific Affairs, LLCTerminated
-
CelgeneActive, not recruiting
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Puerto Rico
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Denmark, Czechia, Israel, Switzerland, Belgium, United Kingdom, Japan, Argentina, Sweden, Canada, Spain, Germany, Netherlands, France, Brazil, Greece, Poland, Ireland, Hungary, Portugal, Australia, F... and more
-
CelgeneCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma | AML | Solid Tumors | MDS | Hodgkin's DiseaseUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, France, Korea, Republic of, Canada, Belgium, New Zealand, Russian Federation